Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 288

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Utility of Anti–Melanoma Differentiation–Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta‐Analysis

Chen, Zhiyong, Cao, Mengshu, Plana, Maria Nieves, Liang, Jun, Cai, Hourong, Kuwana, Masataka, Sun, Lingyun·2013·Arthritis Care & Research

Abstract

Objective: To assess the utility of anti–melanoma differentiation–associated gene 5 (anti‐MDA5) antibody measurement for predicting a risk for developing rapidly progressive interstitial lung disease (RP‐ILD) in patients with polymyositis/dermatomyositis (PM/DM). Methods: A single‐center cohort of 64 consecutive Chinese patients with PM/DM was examined. Serum anti‐MDA5 antibody was measured by enzyme‐linked immunosorbent assay. For meta‐analysis, we searched PubMed and the Institute for Scientific Information Web of Knowledge for original studies that measured anti‐MDA5 antibodies in patients with PM/DM. We calculated pooled sensitivity, specificity, diagnostic odds ratio (DOR), and the summary receiver operating characteristic (sROC) curve. Results: In Chinese patients, anti‐MDA5 antibodies were detected in 26 patients with classic DM or clinically amyopathic DM (CADM). Compared with anti‐MDA5–negative patients, anti‐MDA5–positive patients showed a higher prevalence of RP‐ILD (P = 0.001). In a total of 233 patients with anti‐MDA5 antibody, derived from 16 studies, a higher frequency of CADM was found in Japanese than in non‐Japanese patients (74.7% versus 39.2%; P = 1.2 × 10−7). Meta‐analysis revealed that the pooled sensitivity and specificity of anti‐MDA5 antibody for RP‐ILD was 77% (95% confidence interval [95% CI] 64–87%) and 86% (95% CI 79–90%), respectively. The pooled DOR was 20.41 (95% CI 9.02–46.20) with a favorable area under the sROC curve of 0.89 (95% CI 0.63–0.98). Conclusion: Detection of anti‐MDA5 antibody is a valuable tool for identifying DM patients with a high risk for developing RP‐ILD, but the distribution of classic DM and CADM in patients with this antibody varies among ethnic groups.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/acr.21985

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Cited by

See all 288

Metadata

Authors
Chen, Z., Cao, M., Plana, M. N., Liang, J., Cai, H., Kuwana, M., & Sun, L.
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2013-07-26
Volume
65
Issue
8
Pages
1316-1324
ISSN
  • 0893-7524 (ISSN-L)
  • 2151-464X
  • 2151-4658
OpenAlex
W1479898381
Cited by
288
References
26
FWCI
7.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Utility of Anti–Melanoma Differentiation–Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta‐Analysis. https://app.cochat.ai/papers/10.1002/acr.21985
The paper
Chen, Z., Cao, M., Plana, M. N., Liang, J., Cai, H., Kuwana, M., & Sun, L. (2013). Utility of Anti–Melanoma Differentiation–Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta‐Analysis. Arthritis Care & Research. https://doi.org/10.1002/acr.21985

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.